Intracellular trafficking is the important process that determines the optimal charge ratio on transfection by galactosylated lipoplex in HEPG2 cells.

The purpose of the present study was to gain insight into the major factors affecting transfection efficiency with galactosylated lipoplex in HepG2 cells. In this study, lipoplex and galactosylated lipoplex were examined at different charge ratios (- : +): 1.0 : 1.2, 1.0 : 2.3, 1.0 : 3.1, 1.0 : 4.7, and 1.0 : 7.0. The particle size and zeta potential of the both lipoplexes was dependent on the charge ratio. Cellular uptake was evaluated by using [(32)P]-labeled pCMV-Luc and this showed that the cellular uptake of galactosylated lipoplex was significantly higher than that of lipoplex at a charge ratio ranging from 1.0 : 2.3 to 1.0 : 7.0. As the charge ratio increased in both lipoplexes, the apparent cellular uptake increased. Transfection activity by galactosylated lipoplex was significantly higher than that by lipoplex except at a charge ratio of 1.0 : 7.0. The optimal charge ratio for transfection efficacy was 1.0 : 2.3 and transfection was reduced at higher charge ratios. Both lipoplexes exhibited no significant cytotoxicity at any charge ratio. In conclusion, it is suggested that intracellular trafficking, rather than the degree of uptake and cytotoxicity, is the important process that determines the optimal charge ratio of galactosylated lipoplex in HepG2 cells.

[1]  Leaf Huang,et al.  Overcoming the inhibitory effect of serum on lipofection by increasing the charge ratio of cationic liposome to DNA , 1997, Gene Therapy.

[2]  K. Gounaris,et al.  Granal photosystem II complexes contain only the high redox potential form of cytochrome b-559 which is stabilised by the ligation of calcium , 1995 .

[3]  S. Kawakami,et al.  Asialoglycoprotein receptor-mediated gene transfer using novel galactosylated cationic liposomes. , 1998, Biochemical and biophysical research communications.

[4]  D. Klink,et al.  Nuclear translocation of lactosylated poly-L-lysine/cDNA complex in cystic fibrosis airway epithelial cells. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[5]  D. Liggitt,et al.  Cationic Liposome-mediated Intravenous Gene Delivery (*) , 1995, The Journal of Biological Chemistry.

[6]  J. Northrop,et al.  Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[7]  S. Kawakami,et al.  In Vivo Gene Delivery to the Liver Using Novel Galactosylated Cationic Liposomes , 2000, Pharmaceutical Research.

[8]  S. Kawakami,et al.  Analysis of Hepatic Disposition of Galactosylated Cationic Liposome/Plasmid DNA Complexes in Perfused Rat Liver , 2003, Pharmaceutical Research.

[9]  F. Hirayama,et al.  Enhancing effects of galactosylated dendrimer/alpha-cyclodextrin conjugates on gene transfer efficiency. , 2005, Biological & pharmaceutical bulletin.

[10]  S. Kawakami,et al.  Interaction with Blood Components Plays a Crucial Role in Asialoglycoprotein Receptor-Mediated in Vivo Gene Transfer by Galactosylated Lipoplex , 2005, Journal of Pharmacology and Experimental Therapeutics.

[11]  Leaf Huang,et al.  Time-dependent maturation of cationic liposome–DNA complex for serum resistance , 1998, Gene Therapy.

[12]  Xun Sun,et al.  Targeted gene delivery to hepatoma cells using galactosylated liposome-polycation-DNA complexes (LPD) , 2005, Journal of drug targeting.

[13]  C. Cho,et al.  Synergistic effect of poly(ethylenimine) on the transfection efficiency of galactosylated chitosan/DNA complexes. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[14]  M. Hashida,et al.  Effect of DNA/liposome mixing ratio on the physicochemical characteristics, cellular uptake and intracellular trafficking of plasmid DNA/cationic liposome complexes and subsequent gene expression. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[15]  L. Huang,et al.  A novel cationic liposome reagent for efficient transfection of mammalian cells. , 1991, Biochemical and biophysical research communications.

[16]  S. Kawakami,et al.  Mannose receptor-mediated gene transfer into macrophages using novel mannosylated cationic liposomes , 2000, Gene Therapy.

[17]  R. Kumar,et al.  Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. , 1994, The Journal of biological chemistry.

[18]  S. Kawakami,et al.  Enhanced hepatocyte-selective in vivo gene expression by stabilized galactosylated liposome/plasmid DNA complex using sodium chloride for complex formation. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[19]  M. Monsigny,et al.  Glyco-dependent nuclear import of glycoproteins, glycoplexes and glycosylated plasmids. , 2004, Biochimica et biophysica acta.

[20]  S. Kawakami,et al.  Enhanced gene expression in lung by a stabilized lipoplex using sodium chloride for complex formation , 2005, The journal of gene medicine.

[21]  C. Wu,et al.  Receptor-mediated gene delivery and expression in vivo. , 1988, The Journal of biological chemistry.

[22]  N. Oku,et al.  Increased gene expression by cationic liposomes (TFL-3) in lung metastases following intravenous injection. , 2005, Biological & pharmaceutical bulletin.

[23]  Y. Maitani,et al.  Liver-targeted gene transfer into a human hepatoblastoma cell line and in vivo by sterylglucoside-containing cationic liposomes , 2001, Gene Therapy.

[24]  S. Kawakami,et al.  Effect of galactose density on asialoglycoprotein receptor-mediated uptake of galactosylated liposomes. , 2005, Journal of pharmaceutical sciences.